Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.
Br J Haematol
; 182(4): 590-594, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-28677818
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Marrow
/
Opportunistic Infections
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
CD52 Antigen
/
Agammaglobulinaemia Tyrosine Kinase
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2018
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United kingdom